Core Scientific [CORZ] vs Oracle [ORCL] Detailed Stock Comparison

Core Scientific

NASDAQ
Loading...

Oracle

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Core Scientific wins in 7 metrics, Oracle wins in 10 metrics, with 0 ties. Oracle appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricCore ScientificOracleBetter
P/E Ratio (TTM)-4.0666.08Core Scientific
Price-to-Book Ratio-5.3233.66Core Scientific
Debt-to-Equity Ratio-1.09452.53Core Scientific
PEG Ratio0.04-35.02Oracle
EV/EBITDA-110.3437.37Core Scientific
Profit Margin (TTM)23.71%21.08%Core Scientific
Operating Margin (TTM)-28.13%31.38%Oracle
EBITDA Margin (TTM)N/A31.38%N/A
Return on Equity160.33%69.24%Core Scientific
Return on Assets (TTM)-6.74%7.15%Oracle
Free Cash Flow (TTM)$-52.30M$-394.00MCore Scientific
Dividend YieldN/A0.81%N/A
1-Year Return35.48%65.89%Oracle
Price-to-Sales Ratio (TTM)15.7213.82Oracle
Enterprise Value$6.02B$914.26BOracle
EV/Revenue Ratio17.2915.49Oracle
Gross Profit Margin (TTM)6.39%67.28%Oracle
Revenue per Share (TTM)$1$21Oracle
Earnings per Share (Diluted)$-1.73$4.33Oracle
Beta (Stock Volatility)N/A1.53N/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Core Scientific vs Oracle Stock Performance Analysis

Loading Price Chart...

Core Scientific
Oracle
Core Scientific Stock Overview | Oracle Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Core Scientific0.51%3.35%28.57%20.77%155.13%23.69%
Oracle1.90%3.12%22.27%25.54%129.31%75.62%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Core Scientific35.48%417.63%417.63%417.63%417.63%417.63%
Oracle65.89%353.41%383.65%680.28%908.96%2,268.72%

News Based Sentiment: Core Scientific vs Oracle

Core Scientific

News based Sentiment: MIXED

CoreWeave's month was marked by significant wins – a massive deal with Meta and expansion with OpenAI – but also a challenge from a shareholder urging rejection of the Core Scientific acquisition. This creates a mixed outlook, with high potential offset by deal uncertainty.

View Core Scientific News Sentiment Analysis

Oracle

News based Sentiment: MIXED

October was a pivotal month for Oracle, marked by a massive surge in RPO driven by the OpenAI partnership, but also overshadowed by concerns about rising debt, high valuation, and insider selling. The mixed analyst reactions and regulatory scrutiny add to the complexity, making it a significant month for investors to reassess the risk-reward profile.

View Oracle News Sentiment Analysis

Performance & Financial Health Analysis: Core Scientific vs Oracle

MetricCORZORCL
Market Information
Market Cap i$5.44B$819.55B
Market Cap CategoryMid capMega cap
10 Day Avg. Volume i10,535,81028,166,510
90 Day Avg. Volume i11,982,18329,452,477
Last Close$17.91$291.59
52 Week Range$6.20 - $18.63$118.86 - $345.72
% from 52W High-3.86%-15.66%
All-Time High$18.63 (Nov 25, 2024)$345.72 (Sep 10, 2025)
% from All-Time High-3.86%-15.66%
Growth Metrics
Quarterly Revenue Growth-0.44%0.12%
Quarterly Earnings Growth-0.44%0.00%
Financial Health
Profit Margin (TTM) i0.24%0.21%
Operating Margin (TTM) i-0.28%0.31%
Return on Equity (TTM) i1.60%0.69%
Debt to Equity (MRQ) i-1.09452.53
Cash & Liquidity
Book Value per Share (MRQ)$-3.51$8.50
Cash per Share (MRQ)$1.90$3.87
Operating Cash Flow (TTM) i$12.92M$21.53B
Levered Free Cash Flow (TTM) i$-73,454,624$-2,832,250,112
Dividends
Last 12-Month Dividend Yield iN/A0.81%
Last 12-Month Dividend iN/A$1.70

Valuation & Enterprise Metrics Analysis: Core Scientific vs Oracle

MetricCORZORCL
Price Ratios
P/E Ratio (TTM) i-4.0666.08
Forward P/E i57.4839.96
PEG Ratio i0.04-35.02
Price to Sales (TTM) i15.7213.82
Price to Book (MRQ) i-5.3233.66
Market Capitalization
Market Capitalization i$5.44B$819.55B
Enterprise Value i$6.02B$914.26B
Enterprise Value Metrics
Enterprise to Revenue i17.2915.49
Enterprise to EBITDA i-110.3437.37
Risk & Other Metrics
Beta iN/A1.53
Book Value per Share (MRQ) i$-3.51$8.50

Financial Statements Comparison: Core Scientific vs Oracle

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)CORZORCL
Revenue/Sales i$79.53M$15.90B
Cost of Goods Sold i$71.31M$4.74B
Gross Profit i$8.21M$11.16B
Research & Development iN/A$2.65B
Operating Income (EBIT) i$-42.59M$5.19B
EBITDA i$-641.64M$7.00B
Pre-Tax Income i$580.90M$4.15B
Income Tax i$205,000$725.00M
Net Income (Profit) i$580.69M$3.43B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)CORZORCL
Cash & Equivalents i$697.94M$10.79B
Total Current Assets i$833.18M$24.58B
Total Current Liabilities i$195.51M$32.64B
Long-Term Debt i$1.17B$96.83B
Total Shareholders Equity i$-181.51M$20.97B
Retained Earnings i$-3.15B$-15.48B
Property, Plant & Equipment i$610.44M$0

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)CORZORCL
Operating Cash Flow i$590.74M$5.93B
Capital Expenditures i$-88.42MN/A
Free Cash Flow i$-129.06M$-2.92B
Debt Repayment i$-4.46M$-6.07B
Common Stock Repurchase iN/A$-150.00M

Short Interest & Institutional Ownership Analysis

MetricCORZORCL
Shares Short i55.46M23.58M
Short Ratio i3.570.97
Short % of Float i0.18%0.01%
Average Daily Volume (10 Day) i10,535,81028,166,510
Average Daily Volume (90 Day) i11,982,18329,452,477
Shares Outstanding i292.61M2.81B
Float Shares i278.14M1.67B
% Held by Insiders i0.07%0.41%
% Held by Institutions i0.97%0.45%

Dividend Analysis & Yield Comparison: Core Scientific vs Oracle

MetricCORZORCL
Last 12-Month Dividend iN/A$1.70
Last 12-Month Dividend Yield iN/A0.81%
3-Year Avg Annual Dividend iN/A$1.55
3-Year Avg Dividend Yield iN/A0.36%
3-Year Total Dividends iN/A$4.66
Ex-Dividend DateN/AApr 10, 2025